欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0210/004
药品名称
Reminyl
活性成分
Galantamine hydrobromide 4.0 mg/ml
剂型
Oral solution
上市许可持有人
Janssen-Cilag AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Belgium (BE)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Reminyl 4 mg/ml Lösung zum Einnehmen
France (FR)
Portugal (PT)
Greece (GR)
Spain (ES)
许可日期
2000/07/11
最近更新日期
2025/02/06
药物ATC编码
N06DA04 galantamine
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0210_004_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0210_004_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase